Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 化学 色谱法
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Horizon应助宇宙之王宙斯采纳,获得30
1秒前
2秒前
SN完成签到,获得积分10
3秒前
三三发布了新的文献求助10
4秒前
5秒前
千崧完成签到,获得积分10
6秒前
银点完成签到,获得积分10
7秒前
领导范儿应助风车车采纳,获得10
7秒前
7秒前
华仔应助学术通zzz采纳,获得10
9秒前
Wayne完成签到,获得积分10
9秒前
12秒前
屎蛋发布了新的文献求助10
13秒前
YN完成签到,获得积分10
14秒前
14秒前
Wayne发布了新的文献求助10
14秒前
14秒前
15秒前
16秒前
勤劳的靖儿完成签到,获得积分10
16秒前
16秒前
柒7完成签到,获得积分10
17秒前
科研通AI6.2应助二柱子采纳,获得10
18秒前
科研通AI6.4应助二柱子采纳,获得10
18秒前
19秒前
小璃完成签到,获得积分10
19秒前
19秒前
cheng123发布了新的文献求助10
19秒前
SIDEsss发布了新的文献求助10
19秒前
nic发布了新的文献求助10
20秒前
22秒前
学术通zzz发布了新的文献求助10
22秒前
青情鏖完成签到,获得积分10
23秒前
烟花应助缥缈白翠采纳,获得10
24秒前
24秒前
蓝天发布了新的文献求助30
25秒前
小蘑菇应助1234采纳,获得10
27秒前
lgh发布了新的文献求助10
28秒前
29秒前
TheDing完成签到,获得积分10
29秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Environmental Leverage in Times of Climate Crisis: Product Standards, Carbon Border Measures and Preferential Trade Agreements 1000
Erwählung und Berufung bei Paulus: Bedeutung, Entwicklung und Funktion einer Vorstellung in ihrem frühjüdischen und griechisch-römischen Kontext 850
Matrix Methods in Data Mining and Pattern Recognition 510
Structural Geology: A Quantitative Introduction 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7215968
求助须知:如何正确求助?哪些是违规求助? 8847720
关于积分的说明 18671456
捐赠科研通 6871644
什么是DOI,文献DOI怎么找? 3184785
关于科研通互助平台的介绍 2346460
邀请新用户注册赠送积分活动 2159142